CH593933A5 - - Google Patents

Info

Publication number
CH593933A5
CH593933A5 CH1525676A CH1525676A CH593933A5 CH 593933 A5 CH593933 A5 CH 593933A5 CH 1525676 A CH1525676 A CH 1525676A CH 1525676 A CH1525676 A CH 1525676A CH 593933 A5 CH593933 A5 CH 593933A5
Authority
CH
Switzerland
Application number
CH1525676A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from CH1570773A external-priority patent/CH593930A5/xx
Priority to FR7635316A priority Critical patent/FR2368520B1/fr
Publication of CH593933A5 publication Critical patent/CH593933A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/30Compounds having groups
    • C07C43/315Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1525676A 1972-11-08 1973-11-08 CH593933A5 (el)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7635316A FR2368520B1 (fr) 1973-11-08 1976-11-24 Colorants reactifs avec les fibres, leur preparation et leur utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08
CH1570773A CH593930A5 (el) 1972-11-08 1973-11-08

Publications (1)

Publication Number Publication Date
CH593933A5 true CH593933A5 (el) 1977-12-30

Family

ID=25716890

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1525776A CH587283A5 (en) 1972-11-08 1973-11-08 Omega-norprostaglandins - having prostaglandin like action but having longer lasting and more specific action than PGA, PGE, and PGF
CH1525676A CH593933A5 (el) 1972-11-08 1973-11-08

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1525776A CH587283A5 (en) 1972-11-08 1973-11-08 Omega-norprostaglandins - having prostaglandin like action but having longer lasting and more specific action than PGA, PGE, and PGF

Country Status (1)

Country Link
CH (2) CH587283A5 (el)

Also Published As

Publication number Publication date
CH587283A5 (en) 1977-04-29

Similar Documents

Publication Publication Date Title
CS155031B1 (el)
FR2171183A1 (el)
CS155380B1 (el)
CS155395B1 (el)
CS153302B1 (el)
CS153323B1 (el)
CS153922B1 (el)
CS155091B1 (el)
CS154521B1 (el)
CS154082B1 (el)
CH566945A5 (el)
CH574119A5 (el)
BG19333A1 (el)
BG19854A2 (el)
BG20012A1 (el)
CH1470373A4 (el)
CH559611A5 (el)
CH559637A5 (el)
CH559853A5 (el)
CH562928A5 (el)
CH563094A5 (el)
CH565954A5 (el)
CH566030A5 (el)
CH566525A5 (el)
BG18497A1 (el)

Legal Events

Date Code Title Description
PL Patent ceased